Organon (OGN) Assets (2020 - 2026)
Organon (OGN) posted quarterly Assets of $13.2 billion for Q2 2026, down 2.39% year-over-year from $13.5 billion in Q2 2025, and up 1.4% on a QoQ basis from $13.0 billion in Q1 2026.
Organon (OGN) Assets (2020 - 2026) Analysis & Trends
Organon has reported Assets for 7 years, with the latest figure at $13.2 billion in Q2 2026.
- Assets for Q2 2026 came in at $13.2 billion, down 2.39% year-over-year; the trailing twelve-month figure through Jun 2026 was $13.2 billion (down 2.39% YoY), and the FY2025 annual result was $12.9 billion, down 1.79% from the prior year.
- Assets rose to $13.2 billion in Q2 2026, from $13.0 billion in the prior quarter.
- Over five years, Assets peaked at $13.6 billion in Q3 2025 and troughed at $10.4 billion in Q3 2022.
- A 5-year average of $12.0 billion and a median of $12.1 billion in 2023 frame the typical range for Assets.
- The widest annual swing landed in 2022, when Assets decreased 7.92%; it then increased 15.8% in 2024.
- A 5-year view of Assets shows it stood at $11.0 billion in 2022, then increased by 10.07% to $12.1 billion in 2023, then climbed by 8.65% to $13.1 billion in 2024, then fell by 1.79% to $12.9 billion in 2025, then climbed by 2.42% to $13.2 billion in 2026.
- Per Business Quant data, the three most recent Assets figures were $13.2 billion in Q2 2026, $13.0 billion in Q1 2026, and $12.9 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.56 Bn | 632.80 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 469.72 Bn | 463.15 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 377.32 Bn | 370.18 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 302.80 Bn | 295.11 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 258.16 Bn | 253.26 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 237.16 Bn | 223.17 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 183.24 Bn | 180.06 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 160.63 Bn | 148.93 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Gsk | 106.06 Bn | 101.89 Bn | 8.24 Bn | 82.83 Bn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 13.18 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.18 Bn |
| Mar 31, 2026 | 13.00 Bn |
| Dec 31, 2025 | 12.87 Bn |
| Sep 30, 2025 | 13.55 Bn |
| Jun 30, 2025 | 13.50 Bn |
| Mar 31, 2025 | 13.16 Bn |
| Dec 31, 2024 | 13.10 Bn |
| Sep 30, 2024 | 12.75 Bn |
| Jun 30, 2024 | 12.15 Bn |
| Mar 31, 2024 | 11.89 Bn |
| Dec 31, 2023 | 12.06 Bn |
| Sep 30, 2023 | 11.01 Bn |
| Jun 30, 2023 | 10.98 Bn |
| Mar 31, 2023 | 10.76 Bn |
| Dec 31, 2022 | 10.96 Bn |
| Sep 30, 2022 | 10.44 Bn |
| Jun 30, 2022 | 10.61 Bn |
| Mar 31, 2022 | 10.60 Bn |
| Dec 31, 2021 | 10.68 Bn |
| Sep 30, 2021 | 11.34 Bn |